九强生物：第五届董事会第十七次会议决议公告

Group 1 - The core announcement is that Jiukang Bio has approved the mid-term profit distribution plan for 2025 during its fifth board meeting [2] - The meeting also reviewed multiple proposals, indicating ongoing corporate governance and strategic planning [2] - The announcement was made on the evening of August 26, highlighting the company's commitment to transparency and shareholder communication [2]